U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report By Type, By Modality, By Application, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Modality
  • 1.2.3. Application
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in U.S.
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Modality outlook
  • 2.2.3. Application outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Cancer Contrast Media Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of clinical studies
    • 3.2.1.2. Rising cancer cases
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Side effects and adverse reactions related to contrast agents
    • 3.2.2.2. Presence of alternative imaging options
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing demand for medical imaging
  • 3.2.4. Market challenges analysis
    • 3.2.4.1. Shortage of contrast media due to supply chain disruptions
• 3.3. U.S. Cancer Contrast Media Market: Regulatory Framework and Standards & Compliances
• 3.4. U.S. Cancer Contrast Media Market: Reimbursement Scenario
• 3.5. U.S. Cancer Contrast Media Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Forces
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape

Chapter 4. U.S. Cancer Contrast Media Market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Cancer Contrast Media Market by Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Gadolinium-based Contrast Media
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Iodinated Contrast Media
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Radioactive Agents
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Cancer Contrast Media Market: Modality Estimates & Trend Analysis

• 5.1. Modality Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Cancer Contrast Media Market by Modality Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Nuclear Imaging
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. CT scans
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Mammography
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. MRI scans
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Ultrasound
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Cancer Contrast Media Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Cancer Contrast Media Market by Application Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Breast Cancer
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Bladder Cancer
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Colorectal Cancer
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Lung Cancer
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Prostate Cancer
    • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Bayer AG
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Lantheus
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Bracco
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Guerbet
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Trivitron Healthcare
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Cardinal Health
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Telix Pharmaceuticals Limited
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. GE HealthCare
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. IMAX Diagnostic Imaging
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Nano Therapeutics Pvt. Ltd.
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 U.S. cancer contrast media market, by type, 2018 - 2030 (USD Million)
• Table 3 U.S. cancer contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 4 U.S. cancer contrast media market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in U.S.
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. cancer contrast media market: market outlook
• Fig. 10 U.S. cancer contrast media competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. cancer contrast media market driver impact
• Fig. 16 U.S. cancer contrast media market restraint impact
• Fig. 17 U.S. cancer contrast media market strategic initiatives analysis
• Fig. 18 U.S. cancer contrast media market: Type movement analysis
• Fig. 19 U.S. cancer contrast media market: Type outlook and key takeaways
• Fig. 20 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030
• Fig. 21 Iodinated contrast media estimates and forecast, 2018 - 2030
• Fig. 22 Radioactive agents market estimates and forecast, 2018 - 2030
• Fig. 23 Others estimates and forecast, 2018 - 2030
• Fig. 24 U.S. cancer contrast media Market: Modality movement Analysis
• Fig. 25 U.S. cancer contrast media market: Modality outlook and key takeaways
• Fig. 26 Nuclear imaging market estimates and forecasts, 2018 - 2030
• Fig. 27 CT scans market estimates and forecasts, 2018 - 2030
• Fig. 28 Mammography market estimates and forecasts, 2018 - 2030
• Fig. 29 MRI scans market estimates and forecasts, 2018 - 2030
• Fig. 30 Ultrasound market estimates and forecasts, 2018 - 2030
• Fig. 31 U.S. cancer contrast media market: Application movement analysis
• Fig. 32 U.S. cancer contrast media market: Application outlook and key takeaways
• Fig. 33 Colorectal cancer market estimates and forecasts, 2018 - 2030
• Fig. 34 Bladder cancer market estimates and forecasts, 2018 - 2030
• Fig. 35 Breast cancer market estimates and forecasts, 2018 - 2030
• Fig. 36 Lung cancer market estimates and forecasts, 2018 - 2030
• Fig. 37 Prostate cancer market estimates and forecasts, 2018 - 2030
• Fig. 38 Other market estimates and forecasts, 2018 - 2030
• Fig. 39 Market share of key market players - U.S. cancer contrast media market
• Fig. 40 Key company categorization
• Fig. 41 Company market positioning
• Fig. 42 Key company market share analysis, 2023
• Fig. 43 Strategic framework